… with those treated with androgen deprivation therapy alone, a new … Turin, Italy, and colleagues. Androgen deprivation therapy (ADT) is a cornerstone … 922 received androgen deprivation therapy alone. Patients receiving maximal androgen blockade showed …

… men with prostate cancer receiving androgen deprivation therapy (ADT), oxybutynin led to significant …

… generate the present dataset, androgen deprivation therapy prior to radiotherapy was … Biochemical Parameters During Radiation Therapy The analysis revealed several … CyberKnife stereotactic body radiation therapy for interventional radiologists. Arab …

… received prior treatment with an androgen receptor pathway inhibitor (ARPI).1 … received treatment with apalutamide plus androgen deprivation therapy (ADT) had a statistically significant …

… prednisolone (AAP) in combination with androgen deprivation therapy (ADT) for patients with metastatic …

… the past few years. Androgen deprivation therapy has been the backbone of … have been shown by adding androgen-receptor pathway inhibitors (ARPI) … benefits shown with triplet therapy in those who are … agents such as radioligand therapy with lutetium have shown …

… assigned to receive Erleada plus androgen deprivation therapy (ADT) or ADT alone. In … but still responded to hormone therapy. All patients were treated with … clearer comparison of the two androgen receptor inhibitors. Patients reflected a …

… trial, which evaluated apalutamide plus androgen deprivation therapy (ADT) vs placebo plus ADT … vs 15.0% received prior therapy for localized disease. The dual …

… takes a daily dose of androgen deprivation therapy. And every three months he …

… As reported previously, ERLEADA® plus androgen deprivation therapy (ADT) treatment shows rapid and … ERLEADA® ERLEADA® (apalutamide) is an androgen receptor inhibitor indicated for the … first and only next-generation androgen receptor inhibitor offering a once …